DEST — Destiny Pharma Share News
0.000.00%
Brief: Destiny Pharma Says Cash And Short-Term Deposits At 30 June Of 9.8 Mln Stg
Interim Results
Notice of Interim Results
UK's Destiny Pharma rises after reappointment of chairman
Brief: Destiny Pharma PLC Says Sir Nigel Rudd Returning As Chairman
Brief: Destiny Pharma Identifies New Life Cycle Management Targets For XF-73 Nasal
Positive findings from recent SAB meeting
Brief: Destiny Pharma Sees Several More Potential Partners Of XF-73 Nasal To Be Granted Access In Coming Months
Business Update
Director/PDMR Shareholding
Director Dealing
Brief: Destiny Pharma PLC Appoints Dr Debra Barker Appointed Interim CEO
Dr Debra Barker Appointed Interim CEO
Grant of Share Options
Posting of Annual Report and Notice of AGM
Brief: Destiny Pharma FY Loss Before Tax Of £7.7 Million
Audited results for year ended 31 December 2022
Notice of Results and Investor Presentation
Landmark XF-73 Phase 2 data published in journal